Pandemic Influenza Vaccine (Cell Culture-Based)

About Tiantan Bio

Tiantan Bio's mission is to ensure the supply of safe, effective, and high-quality biological products for public health in China. Its key achievements include establishing one of the nation's most extensive plasma collection networks and a sophisticated manufacturing platform for blood products and vaccines, making it a market leader in its core segments. The company's strategy is centered on deepening its plasma fractionation capabilities, expanding its vaccine portfolio, and advancing a pipeline of novel biologics to address unmet medical needs. Its position within the Sinopharm system provides significant strategic advantages in regulatory alignment and public health procurement.

Therapeutic Areas